Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD19 is a transmembrane glycoprotein expressed on B cells from early pre-B cell stage until differentiation into plasma cells. It functions as a co-receptor in the B cell receptor (BCR) complex, playing a crucial role in B cell development, activation, and immune response regulation. Due to its specific expression pattern, it is a valuable diagnostic marker for B-cell malignancies and a prominent target for immunotherapeutic strategies such as monoclonal antibodies, antibody-drug conjugates, and CAR-T cell therapies.
Antibody-mediated cell killing, receptor blockade, CAR-T cell mediated cytotoxicity
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cluster of Differentiation Antigen 19 (CD19).